Nusinersen sodiumProduct ingredient for Nusinersen
- Name
- Nusinersen sodium
- Drug Entry
- Nusinersen
An antisense oligonucleotide that induces survival motor neuron (SMN) protein expression, it was approved by the U.S. FDA in December, 2016 as Spinraza for the treatment of children and adults with spinal muscular atrophy (SMA). It is adminstrated as direct intrathecal injection.
- Accession Number
- DBSALT002592
- Synonyms
- Not Available
- UNII
- 4CHB7QQU1Q
- CAS Number
- Not Available
- External Links
- Wikipedia
- Nusinersen